Investor Relations

CREATING VALUES AND GROWTH

CORPORATE INFORMATION

  • Company Name

    Jacobson Pharma Corporation Limited

  • Stock Code

    2633

  • Company's website
  • Head Office and Principal Place of Business in Hong Kong

    Unit 2313-18, 23/F, Tower 1 Millennium City 1, 388 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong

  • Registered Office in Cayman Islands

    Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands

  • Board of Directors

    Executive Directors Mr. Sum Kwong Yip, Derek (岑廣業) (Chairman and CEO) Mr. Yim Chun Leung (嚴振亮) Ms. Pun Yue Wai (潘裕慧)

    Non-executive Director Professor Lam Sing Kwong, Simon (林誠光)

    Independent Non-executive Directors Dr. Lam Kwing Tong, Alan (林烱堂) Mr. Young Chun Man, Kenneth (楊俊文) Professor Wong Chi Kei, Ian (黃志基)

  • Company Secretary

    Ms. Wu Lai King

  • Authorized Representatives

    Mr. Yim Chun Leung Ms. Wu Lai King

  • Principal Share Registrar

    Conyers Trust Company (Cayman) Limited Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands

  • Hong Kong Share Registrar

    Tricor Investor Services Limited Level 22, Hopewell Centre, 183 Queen’s Road East, Hong Kong

  • Principal Bankers

    China Construction Bank (Asia) Corporation Ltd. The Hongkong and Shanghai Banking Corporation Limited Standard Chartered Bank

  • Auditors

    KPMG

  • Audit
    Committee

    Mr. Young Chun Man, Kenneth (Chairman)

    Dr. Lam Kwing Tong, Alan

    Professor Wong Chi Kei, Ian

    Terms of Reference
  • Nomination
    Committee

    Professor Wong Chi Kei, Ian (Chairman)

    Dr. Lam Kwing Tong, Alan

    Mr. Young Chun Man, Kenneth

    Mr. Yim Chun Leung

    Terms of Reference
  • Remuneration
    Committee

    Dr. Lam Kwing Tong, Alan (Chairman)

    Mr. Young Chun Man, Kenneth

    Ms. Pun Yue Wai

    Terms of Reference

FINANCIAL HIGHLIGHTS

Five-year Financial Summary

  • Revenue

  • Adjusted Profit Attributable to Shareholders

  • Adjusted EBITDA

  • Net Assets Employed

  • Net Debts

  • Net Gearing Ratio

Revenue

Adjusted Profit Attributable to Shareholders

Adjusted EBITDA

Net Assets Employed

Net Debts

Net Gearing Ratio

ANNOUNCEMENTS & CIRCULARS

PRESS RELEASE & PRESENTATION

2018

STOCK INFORMATION